RecruitingNCT07072143

An International Study on Pediatric Patients With Rare Tumors.

The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.


Sponsor

Azienda Ospedaliera di Padova

Enrollment

6,250 participants

Start Date

Jan 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.


Eligibility

Min Age: 0 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This international study collects clinical data on children and teenagers with rare tumors that are not commonly studied due to their low incidence. The goal is to build a large database to better understand these cancers and improve future treatment options. **You may be eligible if...** - You are a child or adolescent between 0 and 18 years old - You have been diagnosed with a primary or relapsed rare tumor - You are treated at a participating center - A parent or legal guardian has given written consent **You may NOT be eligible if...** - Written consent from a parent or legal guardian has not been obtained Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]

Padova, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07072143


Related Trials